Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
about
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infectionHepatitis B and A vaccination in HIV-infected adults: A reviewStrategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/ AIDS Patients: A Randomized Controlled Trial.Vaccination against viral hepatitis of HIV-1 infected patients.Hepatitis B virus vaccination in HIV-infected people: A review.Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection.Human immunodeficiency virus and liver disease: A comprehensive update.Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant
P2860
Q24193121-91783938-A0AA-442D-8C8B-86177DFFD591Q26799782-1E940473-47E5-4ECB-AC15-29809943EFC2Q34077801-15A84D83-19DD-4A37-B4F5-8BEBC7DCF629Q34405008-A78521D4-6FBC-47D8-9A4E-6202658252D6Q34850890-82DB09E3-5CED-4716-B7F3-F337A1B94857Q35441596-CDA4444A-5B98-4286-9DB6-C6014CD982C9Q36329345-4CA5C4DD-7A88-4F24-875F-C79BEC81A2ACQ38013507-F1482B68-4A7C-421F-836E-AF44BED8A7C1Q39166033-617F5D7C-0CC9-4EAF-B01B-E82A653CAF52Q40180526-805B05E4-EB0D-4390-97D9-0D9AD76C9877Q55109199-7249926F-F9CC-4E72-94B7-7FCA77205CBEQ57824837-F1EA6CFC-F995-4BD3-A475-B7EFF0E0ABFC
P2860
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immune response to hepatitis B ...... ine adjuvant: ACTG study 5220.
@ast
Immune response to hepatitis B ...... ine adjuvant: ACTG study 5220.
@en
Immune response to hepatitis B ...... hage colony-stimulating factor
@nl
type
label
Immune response to hepatitis B ...... ine adjuvant: ACTG study 5220.
@ast
Immune response to hepatitis B ...... ine adjuvant: ACTG study 5220.
@en
Immune response to hepatitis B ...... hage colony-stimulating factor
@nl
prefLabel
Immune response to hepatitis B ...... ine adjuvant: ACTG study 5220.
@ast
Immune response to hepatitis B ...... ine adjuvant: ACTG study 5220.
@en
Immune response to hepatitis B ...... hage colony-stimulating factor
@nl
P2093
P2860
P1433
P1476
Immune response to hepatitis B ...... ine adjuvant: ACTG study 5220.
@en
P2093
B L Alston-Smith
D Demarco-Shaw
E T Overton
H L Sprenger
L Mong-Kryspin
M G Peters
M J Koziel
P2860
P304
P356
10.1016/J.VACCINE.2010.06.030
P407
P577
2010-06-23T00:00:00Z